Article says agency let risky drugs hit market

Source: The Wall Street Journal

An FDA effort to speed approval of new medicines allowed drugs for stroke prevention, cancer and multiple sclerosis onto the market without proper safety analysis, according to two drug-safety experts.

An FDA effort to speed approval of new medicines allowed drugs for stroke prevention, cancer and multiple sclerosis onto the market without proper safety analysis, according to two drug-safety experts.

CPBJ Business Events

2019 Real Estate & Development Symposium

Wednesday, August 07, 2019
2019 Real Estate & Development Symposium

2019 Top 50 Fastest Growing Companies

Monday, September 09, 2019
2019 Top 50 Fastest Growing Companies

2019 Forty Under 40

Monday, October 07, 2019
2019 Forty Under 40

2019 Best Places to Work in PA

Thursday, November 21, 2019
2019 Best Places to Work in PA